Skip to content
Maimon Research LLC

  • Home
  • Distance Education Programs
  • Programs For Purchase
  • Working Papers
  • Questions and Answers
Latest Working Papers

Working Paper No. 6 March 2020 More Unnecessary Imaginary Worlds: The ICER Final Evidence Report for Crizanlizumab, Voxelotor and L-Glutamine for Sickle Cell Disease

March 6, 2020 Dr Paul Langely 696 Views

Paul C. Langley, Ph.D., Adjunct Professor College of Pharmacy, University of Minnesota, MN

The Maimon Working Papers are free to download (in PDF format) at the bottom of the page.
Working-Paper-No.-6-March-2020Download
  • Working Paper No. 5 March 2020 Evading the Question: The EQ-5D and ICER’s Rejection of Fundamental Measurement in Fabricating Imaginary Worlds
  • Where Ignorance is Bliss: The ICER Draft Evidence Report Modeling Imaginary Worlds for Obeticholic Acid for the Treatment of Nonalcoholic Steatohepatitis (NASH) with Fibrosis

DIRECT LINKS

  • LATENT CONSTRUCTS
  • RASCH POSSESSION
  • RASCH NUMBER LINE
  • NUMERICAL STORYTELLING
  • OBJECTIVE KNOWLEDGE
  • LOGIT RATIO SCALE
  • IMPOSSIBLE QALY
  • IMPOSSIBLE REFERENCE CASE
  • VALUE CLAIMS
  • CHEERS 2022 GUIDELINE

Most Viewed Working Papers

  • CORE VALUE CLAIMS, PROTOCOLS AND FORMULARY EVALUATIONS
  • NOTHING TO CHEER ABOUT: ENDORSING IMAGINARY ECONOMIC EVALUATIONS
  • AN ORDINAL OVERSIGHT: ABANDONING THE TUFTS
  • FUNDAMENTAL MEASUREMENT AND THERAPY RESPONSE
  • VALUE CLAIMS AND THE NEW START IN RARE DISEASE
  • REJECTING PSEUDOSCIENCE: TEN COMMANDMENTS
  • EVIDENTIARY STANDARDS FOR PATIENT-CENTRIC CORE IMPACT
  • DAMAGED GOODS: IMAGINARY ICER VALUE ASSESSMENTS
  • MEASUREMENT AND RESPONSE TO THERAPY
Copyright © 2025 Maimon Research LLC. All rights reserved.
Privacy Policy